Background: Mannheimia haemolytica is an important etiological agent in bovine respiratory disease. Objectives: Explore risk factors for recovery of susceptible and resistant M. haemolytica in feedlot cattle and explore associations with health outcomes.
B
ovine respiratory disease (BRD) is a major economic burden to feedlot operators. It is estimated that BRD-associated morbidity and mortality result in annual loss of one billion USD for North American feedlots.
1 BRD-related costs can account for 7% of total production costs, and per-calf revenue losses associated with treatment of BRD are estimated at up to $292 USD for animals requiring 3 antimicrobial treatments. 2, 3 Although the etiology of BRD is multifactorial, M. haemolytica is arguably the most important associated bacterial pathogen, primarily because of virulence factors that induce severe morbidity. M. haemolytica is typically the most common agent isolated from necropsy samples of cattle with BRD. 4, 5 Treatment of BRD in large commercial feedlots is focused on antimicrobial treatment in clinically ill animals and antimicrobial metaphylactic treatment of high-risk animals. Sick animals that fail to respond to initial treatment typically are retreated with a different antimicrobial (personal communication: Calvin Booker). Recently, BRD treatment strategies have come under scrutiny because of a perception of antimicrobial resistance (AMR) in M. haemolytica isolates recovered from feedlot cattle, including multiply-resistant isolates. 6 Despite the putative importance of BRD and M. haemolytica for feedlot economics and animal health, ambiguity persists regarding colonization dynamics of M. haemolytica and associations with clinical disease.
Primary objectives of this study were to describe the prevalence of M. haemolytica in isolates obtained from commercial feedlot beef cattle, to describe resistance prevalence and patterns in isolates, and to investigate associations between antimicrobial use (AMU) and resistant isolates. A secondary objective was to investigate associations between M. haemolytica isolation and morbidity and mortality outcomes.
Materials and Methods

Study Overview
Isolates evaluated in this study were collected as part of a project to develop and evaluate surveillance methods of AMR in feedlots. 7 The study population, sampling methods and laboratory procedures, and interpretive criteria for antimicrobial susceptibility have been described. 7 Briefly, 5,968 individual cattle were enrolled using a 2-stage random sampling as they entered 4 feedlots in Alberta, Canada. Morbidity, mortality and antimicrobial treatment events were tracked throughout the study. Deep nasopharyngeal swabs were collected at arrival to the feedlot ("arrival sample") and again later in the feeding period ("second sample") and cultured for M. haemolytica. Isolates with morphologic characteristics of M. haemolytica were confirmed using biochemical tests and PCR. 7, 8 Confirmed isolates were evaluated for resistance to antimicrobial drugs (AMDs; Table 5 ) using broth microdilution (Table S1 ), disk diffusion (Table S2 ) or both. Prevalence of and risk factors for isolation of M. haemolytica were described, and multivariable logistic regression was used to investigate associations between AMU and AMR in M. haemolytica isolates and between M. haemolytica isolation and health outcomes.
Study Population
Four feedlots in Alberta, Canada with one-time holding capacities of between 15,000 and 20,000 cattle were purposely selected based on their ability to track AMU and other health data as well as their willingness to participate. Production conditions were typical for North American commercial cattle feedlots, and veterinary care was managed by Feedlot Health Management Services (FHMS). Cattle handling and sampling procedures were approved by the Animal Care Committee of the University of Calgary (Protocol Number M07031).
Cattle were sourced from across Canada through auction markets, and entered the feedlots at a range of weights (225-400 kg), ages, frame sizes, and sexes. Based upon these factors and historical patterns of illness in similar cattle, arriving groups were assigned an ordinal category of perceived risk for developing BRD (low risk to very high risk), which was used to employ prevention and treatment protocols. All cattle received a growth implant, vaccines against selected pathogens, and topical anthelmintic upon arrival. Very high risk cattle received M. haemolytica anti-leukotoxin vaccine, and cattle with assigned risk status of very high or high received AMDs as metaphylaxis for respiratory disease, whereas lower risk, non-clinical cattle did not (Table 1) . Cattle in higher risk categories received drugs shown to have greater efficacy for prevention and treatment of respiratory disease. 9 Cattle were fed a diet that met or exceeded the National Research Council requirements for beef cattle until reaching a body weight of 550-650 kg, at which time they were sent to slaughter, typically 120-250 days after arrival in the feedlot.
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Trained feedlot personnel evaluated cattle for signs of illness at arrival and daily thereafter. Animals exhibiting systemic illness (eg, dyspnea, lack of response to stimulation, reluctance to move, abnormal carriage or posture of the head, or some combination of these signs) were assigned a diagnosis of "undifferentiated systemic illness" with or without fever based on a body temperature of higher or lower than 40.5°C, respectively, and treated using antimicrobial protocols formulated specifically for their diagnosis and risk status. All cattle that died underwent necropsy by a FHMS veterinarian, who used clinical history and physical findings to classify the cause of death as either BRD, bovine viral diarrheaassociated disease, disease caused by Histophilus somni, diseases of the appendicular skeleton, metabolic disease, and miscellaneous heath events (eg, trauma). 
Animal and Pen Record Management
A computerized data collection system a was used to track the date each animal arrived at the feedlot, the number of cattle in the pen, the BRD risk status of each animal, and all health events, including treatments (date, drug administered, dose, and route of administration) and clinical and necropsy diagnoses. Only in-feedlot AMD exposures were included in this study because of a lack of information on management of cattle before arrival in the feedlot. Most cattle's pen assignments did not change after arrival, exceptions being pens that were split or mixed for the purposes of marketing homogenous groups of cattle; such pens were excluded from analysis because of an inability to accurately characterize AMU for penmates. Nasopharyngeal sample collection dates, culture results, M. haemolytica isolate identification numbers, and resistance testing results were compiled and linked using the unique animal identification assigned to each animal upon arrival.
Data Analysis
Descriptive analyses and data distributions were explored graphically and using numerical summaries. Adjusted CI for binomial proportions (adding 2 successes and 2 failures) were estimated. 11 Crude prevalence of susceptible and resistant M. haemolytica at arrival and second sampling was calculated and compared. When drugs were tested by both broth microdilution and disk diffusion (eg, ampicillin, ceftiofur), isolates were classified as resistant if either test result indicated resistance. "Pan-susceptibility" was defined as phenotypic susceptibility to all drugs tested. "Multiple resistance" was defined as phenotypic resistance to ≥2 antimicrobials, regardless of drug class and whether results were obtained from broth microdilution or disk diffusion, because the drugs included in these panels differed. McNemar's test was used to detect significant differences in isolation of M. haemolytica within individual cattle between the 2 sampling points. Leastsquare means estimates from generalized estimating equations (GEE) were used to determine significant changes in the overall prevalence of M. haemolytica between the 2 sampling points, with cattle ID specified as a repeated measure.
Inferential analyses were performed with commercial software b using logistic regression with GEE to control for clustering within pens, specifying an exchangeable correlation structure. Feedlot was included in all models as a fixed effect. The distributions of AMU were strongly right-skewed and zero-inflated, and therefore were modeled dichotomously (ie, no exposure versus any exposure). Each antimicrobial class (tetracycline, macrolide, beta-lactam, phenicol, sulfonamide, and quinolone) and route of exposure (in-feed versus parenteral) was modeled separately. Parenteral drugs were grouped into a single variable if exposures were too sparse for model convergence. The primary study outcome was isolation of M. haemolytica (yes or no) in the second sample. Primary exposure variables of interest were previous exposure to parenteral antimicrobials of any type, and in-feed macrolides and tetracyclines. Exposures were classified as direct (ie, administered directly to the enrolled individual) or indirect (ie, administered to penmates of the enrolled individual). Furthermore, exposures were dichotomized as occurring >7 or ≤7 days from sample collection. Arrival sample M. haemolytica status (positive or negative) and cattle risk level also were risk factors of interest. Pen size was added as a potential confounder.
Secondary outcomes were resistance in second sample M. haemolytica isolates, both to each of the 21 drugs tested in the 2 panels, as well as to ≥2 drugs, that is multiply-resistant (ie, multiply-resistant versus singly-resistant or susceptible). Isolates tested by broth microdilution and disk diffusion were considered multiply-resistant if either method showed multiple resistance. Primary exposure variables included individual and penmate parenteral exposure to betalactams, sulfonamides, phenicols, quinolones, macrolides, and tetracyclines and in-feed macrolides and tetracyclines at any point before sample collection. For the outcome of multiply-resistant M. haemolytica, all parenterally administered drugs were grouped together into a single exposure variable. M. haemolytica status of cattle at arrival was the primary risk factor of interest for resistance outcomes. Secondary risk factors included the season of feedlot arrival and sample collection (Jan-Mar, Apr-Jun, Jul-Sept, Oct-Dec), the risk status assigned to each animal (low, medium, high, or very high), and the number of cattle in the pen (<100, 101-200, 201-300, 301-400, or >400). The number of days cattle had been in the feedlot at sample collection was forced into all models as a potential confounder. To account for repeated measures on samples from testing of multiple isolates, we specified "sample" as a subcluster with a "1-(nested log odds ratio)" structure using GEE with alternating logistic regression (ALR).
12 Some isolates were tested by both broth microdilution and disk diffusion, and therefore "test type" was added as a fixed effect.
To model isolation of susceptible and resistant M. haemolytica, each AMU variable was first modeled individually. Variables exhibiting a P value of ≤.20 were included in multivariable modeling, which proceeded in a backwards stepwise fashion with a critical alpha for retention of 0.05. Variables with a relatively large effect size and biological relevance also were retained in the final model. Confounding (defined as parameter estimate change of ≥20%) was assessed for all excluded variables. Collinearity was evaluated using the variance inflation factor and Chi-square test for continuous and categorical variables, respectively. 13 A third set of outcomes included BRD-associated mortality and morbidity (diagnosis of systemic illness with fever at arrival, at any time during the study period, and within 10 days after sample collection). For these 4 outcomes, the primary risk factor of interest was arrival sample M. haemolytica status. Secondary a priori risk factors included in all models were BRD risk status, number of cattle in the pen, and the season of arrival. 
Results
Samples
Study Population
The 5,498 cattle represented a diversity of BRD risk categories (Table 2) . Most cattle were housed with 101-300 animals (59.4%, 3,267/5,498), and entered the feedlot in the summer and fall (68.6%, 3,771/5,498).
Prevalence of Mannheimia haemolytica Recovery
A total of 10,477 nasopharyngeal samples were obtained, and M. haemolytica was isolated from 16.6% (1,744/10,477; 95% CI, 15.9-17.4%). Overall, 29% of cattle (1,596/5,498) were culture-positive for M. haemolytica at least once, and there was significant discordance in recovery likelihood between arrival and second samples (McNemar's P < .001), that is, a majority of positive cattle (90.7%; 1,448/1,596) were culture-positive only once. There was a significant increase (P < .001) in the likelihood of recovery from arrival to second sample (13.1%; 95% CI, 12.3-14.1% and 19.8%; 95% CI, 18.7-20.9, respectively).
Antimicrobial Use
All enrolled cattle received tetracycline and 9.6% (477/4,979) received macrolides in-feed for liver abscess control before second sampling (Table 3) . Parenteral drugs were given to 47.5% (2,611/5,498) of enrolled cattle, most commonly during initial processing as metaphylaxis for respiratory disease. Tetracyclines and macrolides were the most common parenterally administered antimicrobials, with 31% (1,563/4,979) and 23% (1,158/4,979) of enrolled cattle exposed during the study, respectively. Other parenterally administered AMDs were each given to <2% of study cattle.
Risk Factors for Recovery of M. haemolytica
Odds of isolating M. haemolytica in second samples from cattle that received any parenterally administered drug ≤7 days preceding sample collection were about 5 times lower than for cattle that did not receive parenterally administered drugs in this same timeframe (OR, 0.2; 95% CI, 0.02-1.2; P = .006; Table 4 ). Nontreated enrolled cattle housed in a pen with cattle that received injections >7 days before sample collection were about 1.5-times more likely to be colonized with M. haemolytica than study cattle that did not have treated penmates (OR, 1.5; 95% CI, 1.05-2.2; P = .02; Table 4 ). Arrival sample M. haemolytica status was not significantly associated with second sample M. haemolytica status. BRD risk status was collinear with AMD exposure and could not be modeled.
Antimicrobial Resistance
Susceptibility testing was performed on 2,989 isolates taken from 1,744 culture-positive nasopharyngeal samples. A total of 1,200 isolates were tested with only broth Table 5 ). The relatively low prevalence of resistance across all drugs is also reflected in the distributions of minimum inhibitory concentration (MIC) and zone diameter data (Tables S3, S4 ). Spectinomycin exhibited the highest resistance prevalence at 4.5% (81/1,789), followed by tetracycline (4.4%, 204/4,622), streptomycin (4.3%, 119/2,833), and kanamycin (3.8%, 108/2,833; Table 5 ). No AMD exposures were significantly associated with resistance to any of these 4 drugs. A subset of the 2,989 isolates tested for susceptibility (8.6%, 415/2,989) was excluded from inferential analyses of resistant M. haemolytica because of missing AMD exposure information when pens were split or mixed before sampling. A small proportion of remaining isolates was multiply-resistant (5.9%; 152/2,573; 95% CI, 5.1-6.9%), comprising 3.8% of arrival isolates (47/1,225; 95% CI, 2.9-5.1%) and 7.8% of second sample isolates (105/1,348; 95% CI, 6.5-9.4%). Combined kanamycin and streptomycin resistance was the most common multiple-resistant phenotype at 47.1% (80/170; 95% CI, 39.7-54.5%; Table 6 ). Although multiple resistance was rare, odds of recovery was much greater when penmates of sampled individuals received parenterally administered AMDs (OR, 23.9; 95% CI, 8.4-68.3; P < .001; Table 7 ). The wide CI for this estimate indicates a predictable lack of precision given the relatively rare occurrence of multiple resistance. Parenteral AMU in sampled cattle also was associated with increased odds of recovering multiply-resistant M. haemolytica from second samples, but was collinear with parenteral exposure in penmates; individual exposures were removed from the model because of a weaker magnitude of effect on recovery of multiplyresistant M. haemolytica. Multiple-resistance status was Table 5 . Crude prevalence of resistance of M. haemolytica isolates (n = 2,989). Isolates can be listed more than once if they were multiply resistant; 1,574 isolates were tested by both broth microdilution and disk diffusion, 1,200 isolates were tested by only broth microdilution, and 215 isolates tested only by disk diffusion, for a total of 2,833 test results from broth microdilution and 1,789 from disk diffusion (4,622 total test results). Adjusted CI for binomial proportions (adding 2 successes and 2 failures) were estimated as previously described. 
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Morbidity and Mortality
Overall, 7% of enrolled cattle (401/5,498) were diagnosed with systemic illness requiring treatment, 19% of which were febrile at arrival (75/401), 50% of which became systemically ill and febrile while in the feedlot (200/401), and 31% of which became ill during the feeding period but were not febrile (126/401). Of the 401 sick cattle, 41% (164/401) were diagnosed as ill <10 days after sample collection, the majority (95.7%; 157/164) <10 days after arrival sampling. Approximately 1.3% of enrolled cattle died during the study (71/5,498), with 21% (15/71) attributed to metabolic disease, 21% (15/71) to Histophilus somni, 13% (9/71) to lameness, 11% (8/71) to BRD, and 3% (2/71) to mucosal disease caused by bovine viral diarrhea virus. The remaining 31% (22/71) succumbed to miscellaneous causes.
M. haemolytica Isolation as a Risk Factor for Respiratory Morbidity and Mortality
Isolation of M. haemolytica at arrival was not a significant predictor of mortality, arrival diagnosis with systemic illness and fever, or diagnosis of systemic illness and fever later in the feeding period (Table 8) . However, cattle that were culture-positive for M. haemolytica on arrival had almost twice the likelihood of being identified as systemically ill and febrile <10 days after arrival as compared to culture-negative cattle (OR, 1.7; 95% CI, 1.1-2.4; P = .07).
Discussion
Mannheimia haemolytica prevalence in this study was similar to that of previous reports, 3, 14 but recovery was significantly lower at arrival than later in the feeding period. Almost 90% of isolates were susceptible to all AMDs evaluated (21 AMDs from 9 different drug classes), and only approximately 6% were multiply-resistant. The likelihood of recovery was decreased in cattle that received AMDs parenterally, but increased in untreated cattle whose penmates received antimicrobials parenterally, which may be an indicator of contagious transmission within pens. In addition, parenteral AMD exposures in penmates greatly increased the odds of recovering multiply-resistant M. haemolytica in study subjects.
These findings are especially relevant to producers and their veterinarians, because they stem from a longitudinal study conducted in commercial cattle under typical feedlot conditions. Deep nasopharyngeal sampling was done on live feedlot cattle regardless of clinical signs, as opposed to sampling necropsy lung tissues, and therefore provides a potentially more relevant picture of M. haemolytica transmission dynamics. Although live animal sampling is unique, it must be noted that cattle were sampled only twice and outcomes therefore represent only a snapshot of M. haemolytica feedlot dynamics.
All cattle were exposed to in-feed AMDs and 50% to parenterally administered AMDs, primarily for BRD metaphylaxis. Most AMDs used in this population were macrolides and tetracyclines, while other classes were relatively infrequently used, including antimicrobials germane to AMR in M. haemolytica (eg, ceftiofur). Although these AMD use patterns reflect real world practices, they can also hamper analytic analysis because of sparse data distributions for AMD exposure measures, as well as rare resistance outcomes. Given low parenteral AMU rates, randomized controlled trials may be necessary to evaluate specific hypotheses regarding the impact of use on M. haemolytica recovery and AMR, particularly for specific resistances that pose substantial human, animal, or economic health risk. However, we believe that the observational nature of this study better reflects real world ecological impact of AMU on M. haemolytica recovery and AMR.
A striking finding of this study is that parenteral AMU in penmates not only modestly increased the odds of isolating any M. haemolytica but also dramatically increased the likelihood of recovering rare multiply-resistant isolates (Tables 4, 7) . Parenteral treatment is a marker of disease occurrence under the management strategy used in this population, and therefore this finding could suggest that contagious spread is predicted by disease occurrence in penmates. If this is true, the use of arrival metaphylaxis in high-risk populations may be effective in controlling disease in clinically ill cattle, as well as preventing colonization of healthy penmates. 9, 15, 16 However, it might also suggest that treatment selects for more resistant bacterial populations, which spread among penmates. Indeed, this theory is supported by the large effect of parenteral treatment on increasing the likelihood of isolating multiply-resistant M. haemolytica. Together, these findings suggest that metaphylaxis treatment protocols may be striking a delicate balance between the competing interests of animal health and antimicrobial resistance. This ecological impact warrants further investigation given the importance of M. haemolytica in feedlot cattle.
We also found that feedlot-of-origin exhibited a strong and consistent association with the 4 single-resistance outcomes that could be modeled (ie, spectinomycin, tetracycline, kanamycin, and streptomycin). If M. haemolytica undergoes contagious spread, we would expect resistance patterns to be strongly associated with geographic location (ie, feedlot). Indeed, the contagious nature of M. haemolytica previously has been suggested based on evidence of BRD clustering within transport trucks and pens.
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This finding also suggests that M. haemolytica subpopulations may undergo clonal expansion, and that resistant strains are maintained at low levels within a feedlot. Previous studies have shown a link between resistance patterns and M. haemolytica subtype. 18 Furthermore, the significant increase in prevalence of M. haemolytica from arrival to second samples (13-20%) could suggest that phenotypic characteristics (eg, virulence) of Published rates of multiply-resistant M. haemolytica range from 0 to 50%, but it is difficult to compare the prevalence found in this study, because the only identified studies used small numbers of young animals in noncommercial settings (sample sizes ranging from 4 to 27). [20] [21] [22] [23] One recent, larger study examined samples from over 350 cattle and found an increase in multiplyresistant M. haemolytica from 5 to 35% between 2009 and 2011, but evaluated only isolates from cattle with terminal respiratory disease. 6 As stated above, information regarding M. haemolytica susceptibility obtained from our study is particularly relevant to veterinarians and producers because isolates were obtained from randomly selected live cattle without considering treatment history or disease status.
Several lines of evidence indicate that isolates obtained in this study were representative of a highly susceptible bacterial population. The majority of M. haemolytica isolates (88%) were pan-susceptible, there was low resistance prevalence to all drugs, and distributions of susceptibility information (MICs and zones of inhibition) were highly suggestive of a largely susceptible population. The prevalence of multiply-resistant M. haemolytica isolates also was much lower than indicated by other recent research. 6 In addition to a largely susceptible bacterial population, it should be noted that no associations were found between AMD exposures among enrolled cattle or their penmates, and resistance to single drugs. Furthermore, the most prevalent resistance phenotypes observed were for AMDs not used in the study population (eg, kanamycin, streptomycin, and spectinomycin). This finding is consistent with a recent study that showed no correlation between antemortem treatment regimens and resistance patterns in M. haemolytica recovered from necropsy lung samples. 24 Together, these findings highlight the complexity of AMR and suggest that AMU practices do not necessarily impact development of AMR in a predictable manner. Furthermore, these results support the contention that decreased efficacy of BRD treatment stems from chronic and repeatedly treated BRD cases, rather than from AMU practices. The association between treatment with parenterally administered antimicrobials and recovery of multiply-resistant M. haemolytica deserves closer study to determine whether this relationship affects BRD control or treatment efficacy in feedlot populations.
Recovery of M. haemolytica from 20% of cattle after arrival was higher than expected, as was the significant increase in prevalence over time. However, recovery of M. haemolytica in the second sample was not associated with increased morbidity or mortality, suggesting that post-arrival colonization is more likely to be subclinical and may not be as great a concern for feedlot operators. In contrast, isolation of M. haemolytica on arrival was associated with a short-term, significant increase in risk of clinical illness. Thus, although prevalence of M. haemolytica was lower at arrival, the clinical and economic relevance of such colonization was greater. In addition, these results showed that cattle receiving parenterally administered drugs were at decreased risk of M. haemolytica colonization in the short-term, a finding that supports AMU in high-risk individuals during a defined period of stress, such as arrival in the feedlot. These findings highlights the complexity of colonization, treatment and clinical illness, and support the belief that aggravating factors such as transport and handling stress are critical for causing cattle to develop overt disease. 
Supporting Information
Additional Supporting Information may be found online in Supporting Information: Table S1 . M. haemolytica broth microdilution interpretive criteria for minimum inhibitory concentration (lg/mL). Table S2 . M. haemolytica disk diffusion interpretive criterian for inhibition zone diameters (mm). Table S3 . Minimum inhibitory concentrations for Mannheimia haemolytica isolates recovered from deep nasopharyngeal swabs obtained from feedlot cattle (n = 2,833 isolates). Table S4 . Results of disk diffusion susceptibility testing of Mannheimia haemolytica isolates recovered from deep nasopharyngeal swabs obtained from feedlot cattle (n = 1,789 isolates).
